INHOMEPHARMACY LLC — United States · Federal contract register · Supplier record: 5 contracts, all years ($1,014,952 · Mar 2020 – Apr 2026); $167K since January 2024 (2 contracts · 1 agency); — rank in the line (of 1,457 suppliers · 0.0%); 1 agencies never served ($509M on the line without INHOMEPHARMACY LLC).
Assay record ASY-US-1VFR53N1OQ · Cite as: Assay Systems, “INHOMEPHARMACY LLC in the USAspending register”, https://assay-systems.com/register/us/inhomepharmacy-llc/
5
contracts, all years
$1,014,952 · Mar 2020 – Apr 2026
$167K
since January 2024
2 contracts · 1 agency
—
rank in the line
of 1,457 suppliers · 0.0%
1
agencies never served
$509M on the line without INHOMEPHARMACY LLC
Own record by year
2020 onward
$50.0K
$48.6K
$749K
$142K
$25.0K
2020202120222023202420252026
Who buys from INHOMEPHARMACY LLC
since January 2024
1agencies
$167Kpaid
100.0%top buyer
Department of Defense100.0%
$166,975
The line
since January 2024
$10.2Bline value
3,580contracts
2agencies
1,457suppliers
63.6%held by top ten
National defense r&d services; defense-related activities; applied research (AC32)
$6.3B
$3.2B
$646M
202420252026Jan–Sep
—of 1,457 suppliers
$0INHOMEPHARMACY LLC in the line
0.0%share of the line
Agencies that buy the line and never bought from INHOMEPHARMACY LLC
1agencies
2contracts
$509,117,561since January 2024
General Services Administration2 contracts
$509,117,561
How the line is bought
by value, since 2024
39%no competition
19%one applicant
0of these to INHOMEPHARMACY LLC
Competed, several suppliers applied2,277 contracts
Source: USAspending.gov, U.S. Department of the Treasury, Bureau of the Fiscal Service, usaspending.gov, accessed 30 September 2026.The data is available to copy, adapt, redistribute, or otherwise use for non-commercial or for commercial purposes (USAspending.gov, Licensing); no Dun & Bradstreet data is shown.